BRIEF published on 05/12/2025 at 07:35, 1 year 5 months ago Promising data for MaaT033 in ALS Microbiome Amyotrophic Lateral Sclerosis MaaT033 Safety And Tolerability Phase 1b Clinical Trial
PRESS RELEASE published on 05/12/2025 at 07:30, 1 year 5 months ago Informations privilégiées / Autres communiqués MaaT Pharma annonce des données finales prometteuses pour son essai de Phase 1b évaluant MaaT033 dans la Sclérose Latérale Amyotrophique (SLA). Résultats encourageants et implications thérapeutiques importantes Microbiome Ecosystem Therapies MaaT Pharma Sclérose Latérale Amyotrophique Phase 1b Modulation Du Microbiote
BRIEF published on 04/08/2025 at 07:35, 1 year 7 months ago MaaT Pharma Announces Positive Interim Safety Results for MaaT033 Phase 2B Trial MaaT Pharma MaaT033 Allo-HSCT DSM Safety
BRIEF published on 04/08/2025 at 07:35, 1 year 7 months ago MaaT Pharma annonce des résultats intermédiaires positifs concernant l'innocuité du MaaT033 MaaT Pharma Essai De Phase 2b MaaT033 Allo-GCSH Sécurité DSM
PRESS RELEASE published on 04/08/2025 at 07:30, 1 year 7 months ago Inside Information / Other news releases MaaT Pharma announces positive safety interim analysis from DSMB for Phase 2b trial evaluating MaaT033 for patients receiving Allo-HSCT, demonstrating favorable safety profile and tolerability Phase 2B Trial MaaT Pharma Safety Analysis MaaT033 Allo-HSCT
PRESS RELEASE published on 04/08/2025 at 07:30, 1 year 7 months ago Informations privilégiées / Autres communiqués MaaT Pharma annonce résultat positif analyse intermédiaire sécurité essai clinique Phase 2b MaaT033 allo-GCSH. DSMB recommande poursuite essai sans modification Sécurité DSMB MaaT Pharma Analyse Intermédiaire Allo-GCSH
BRIEF published on 04/07/2025 at 07:35, 1 year 7 months ago MaaT Pharma : Nouvelle couverture par H.C. Wainwright & Co Cancer Cotation Euronext Microbiome Ecosystem Therapies MaaT Pharma H.C. Wainwright & Co
BRIEF published on 04/07/2025 at 07:35, 1 year 7 months ago MaaT Pharma: New cover by HC Wainwright & Co Cancer Euronext Listing Microbiome Ecosystem Therapies MaaT Pharma HC Wainwright & Co
PRESS RELEASE published on 04/07/2025 at 07:30, 1 year 7 months ago Informations privilégiées / Autres communiqués MaaT Pharma annonce l'initiation de la couverture de son titre par H.C. Wainwright & Co, une banque d'investissement américaine, renforçant sa présence sur le marché américain Oncologie Couverture MaaT Pharma Biotechnologies H.C. Wainwright & Co
BRIEF published on 03/27/2025 at 07:35, 1 year 7 months ago MaaT Pharma annonce une augmentation de capital de 13 millions d'euros et des résultats annuels 2024 Résultats Financiers Biotechnologie Augmentation De Capital MaaT013 AGvH
Published on 11/10/2026 at 02:45, 3 hours 29 minutes ago Presentation to Zurich Precious Metals Summit
Published on 11/09/2026 at 23:00, 7 hours 14 minutes ago LNG Energy Group Announces Issuance of Third Partial Revocation Order and Proposed Shares-for-Debt Settlement
Published on 11/09/2026 at 22:32, 7 hours 42 minutes ago Announces Extension for Closing of Private Placement of Convertible Promissory Notes
Published on 11/09/2026 at 22:15, 7 hours 59 minutes ago Goldcliff Announces Closing of the Second and Final Tranche of its "LIFE" Offering and Completion of Drilling at Kettle Valley
Published on 11/10/2026 at 06:00, 14 minutes ago Ad hoc announcement pursuant to Art. 53 LR 10 November 2026
Published on 11/10/2026 at 04:55, 1 hour 19 minutes ago The 19th Europe-China Business and Technology Cooperation Fair boosts business cooperation
Published on 11/10/2026 at 01:20, 4 hours 54 minutes ago US defence customer steps up orders and first graphene oxide orders secured
Published on 11/09/2026 at 22:54, 7 hours 20 minutes ago EQS-Adhoc: Northern Data Group reports Q3 2026 and raises its FY 2026 revenue outlook communicated on 17 June 2026
Published on 11/09/2026 at 18:30, 11 hours 44 minutes ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
Published on 11/09/2026 at 18:30, 11 hours 44 minutes ago Air Liquide a réalisé avec succès une émission obligataire multi-tranches de 390 millions de CHF
Published on 11/09/2026 at 17:45, 12 hours 29 minutes ago Déclaration hebdomadaire de rachat d'actions
Published on 11/09/2026 at 17:45, 12 hours 29 minutes ago Déclaration des droits de vote à fin octobre 2026
